Alkermes PLC (NAS:ALKS)
$ 24.48 0.14 (0.58%) Market Cap: 4.14 Bil Enterprise Value: 3.74 Bil PE Ratio: 9.68 PB Ratio: 3.30 GF Score: 66/100

Alkermes Plc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2022 / 04:15PM GMT
Release Date Price: $22.52 (-3.16%)
Cory William Kasimov
JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst

All right. Good morning from the 40th Annual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the senior large-cap biotech analyst, and it's my pleasure to introduce Alkermes and Chairman and CEO, Richard Pops.

Please note that following the presentation, we will move right into Q&A, where you can send in your questions via the conference portal, and I'll do my best to work them into the conversation.

So with that, Rich, thanks as always for joining us today, and let me turn things over to you for the latest on Alkermes.

Richard F. Pops
Alkermes plc - Chairman & CEO

Great. Thanks, Cory. It's great to see you and not see everybody else at this moment. But I understand the slides are going to work is that you'll drive them from the audience. So I'm going to give you a sense of where we are in the presentation as we go.

This presentation was designed to give you a sense of how significantly and deliberately, we've

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot